Search Results - Valldeoriola F
-
1
Spanish expert consensus on the use of safinamide in Parkinson's disease.
Article | by Valldeoriola F; Grandas F; Arbelo JM; Blázquez Estrada M; Calopa Garriga M; Campos-Arillo VM; Garcia Ruiz PJ; Gómez Esteban JC; Leiva Santana C; Martínez Castrillo JC; Mir P; Salvador Aliaga A; Vivancos Matellano F; Yáñez Baña RM | Published 2018 | -
2
Spanish expert consensus on the use of safinamide in Parkinson's disease.
Article | by Valldeoriola F; Grandas F; Arbelo JM; Blázquez Estrada M; Calopa Garriga M; Campos-Arillo VM; Garcia Ruiz PJ; Gómez Esteban JC; LEIVA, CARLOS; Martínez Castrillo JC; Mir P; Salvador Aliaga A; Vivancos Matellano F; Yáñez Baña RM | Published 2018 | -
3
Present and Future of Parkinson's Disease in Spain: PARKINSON-2030 Delphi Project
Article | by Garcia, DS; Blazquez-Estrada, M; Calopa, M; Escamilla-Sevilla, F; Freire, E; Ruiz, PJG; Grandas, F; Kulisevsky, J; Lopez-Manzanares, L; Castrillo, JCM; Mir, P; Pagonabarraga, J; Perez-Errazquin, F; Salom, JM; Tijero, B; Valldeoriola, F; Yanez, R; Aviles, A; Luquin, MR | Published 2021 |Other Authors: “…Valldeoriola, F…”
-
4
Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study
Article | by Valldeoriola, F; Regidor, I; Minguez-Castellanos, A; Lezcano, E; Garcia-Ruiz, P; Rojo, A; Salvador, A; Castro, A; Grandas, F; Kulisevsky, J; Marti, MJ; Martinez-Martin, P; Relova, L; Rumia, J; Camara, A; Burguera, JA; Linazasoro, G; de Val, JL; Obeso, J; Rodriguez-Oroz, MC; Tolosa, E | Published 2010 | -
5
Phenotypic Variability Within the Inclusion Body Spectrum of Basophilic Inclusion Body Disease and Neuronal Intermediate Filament Inclusion Disease in Frontotemporal Lobar Degenera...
Article | by Gelpi, E; Llado, A; Clarimon, J; Rey, MJ; Rivera, RM; Ezquerra, M; Antonell, A; Navarro-Otano, J; Ribalta, T; Pinol-Ripoll, G; Perez, A; Valldeoriola, F; Ferrer, I | Published 2012 |Other Authors: “…Valldeoriola, F…”
-
6
Erratum: Pagonabarraga, J.
Article | by Pagonabarraga, J. (Javier)|||/items/11fa7b60-f13e-4cc2-bb32-eb486349545d; Arbelo-González, J.M. (José Matías)|||/items/21116843-e426-4991-9ec1-b4161240ed13; Grandas, F. (Francisco)|||/items/ba56edb2-fc66-444d-aa9f-75c71d9e5c4f; Luquin-Piudo, M.R. (María Rosario)|||/items/6449c359-8b33-4ca4-9ff1-ca1505be7ed3; Martinez-Martin, P. (Pablo)|||/items/eaea88d2-7b1b-4d23-aa23-33fa883fae3c; Rodriguez-Oroz, M.C. (María Cruz)|||/items/ba71432e-1a59-4a6d-87af-ba74627ba030; Valldeoriola, F. (Francesc)|||/items/4c3e766a-b90c-449c-aa84-3bf95fbd17b5; Kulisevsky, J. (Jaime)|||/items/b2ecf863-734d-4e63-9198-4be17e3a25b3 | Published 2020 |Other Authors: “…Valldeoriola, F. (Francesc)|||/items/4c3e766a-b90c-449c-aa84-3bf95fbd17b5…”
-
7
Exome-wide rare variant analysis in familial essential tremor
Article | by Diez-Fairen, M; Houle, G; Ortega-Cubero, S; Bandres-Ciga, S; Alvarez, I; Carcel, M; Ibanez, L; Fernandez, MV; Budde, JP; Trotta, JR; Tonda, R; Chong, JX; Bamshad, MJ; Nickerson, DA; Aguilar, M; Tartari, JP; Gironell, A; Garcia-Martin, E; Agundez, JAG; Alonso-Navarro, H; Jimenez-Jimenez, FJ; Fernandez, M; Valldeoriola, F; Marti, MJ; Tolosa, E; Coria, F; Pastor, MA; Vilarino-Guell, C; Rajput, A; Dion, PA; Cruchaga, C; Rouleau, GA; Pastor, P; UMCMG | Published 2021 |Other Authors: “…Valldeoriola, F…”
-
8
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
Article | by Antonini, A; Poewe, W; Chaudhuri, KR; Jech, R; Pickut, B; Pirtosek, Z; Szasz, J; Valldeoriola, F; Winkler, C; Bergmann, L; Yegin, A; Onuk, K; Barch, D; Odin, P; Kulisevsky J. | Published 2017 |Other Authors: “…Valldeoriola, F…”
- 9
-
10
Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus
Article | by Stocchi, F; Antonini, A; Berg, D; Bergmans, B; Jost, W; Katzenschlager, R; Kulisevsky, J; Odin, P; Valldeoriola, F; Chaudhuri, KR | Published 2022 |Other Authors: “…Valldeoriola, F…”
Search Tools:
Related Subjects
Parkinson's disease
Article
Parkinson disease
human
Dyskinesia
Fluctuations
Glutamate
MAO-B inhibitors
Parkinson
Safinamide
age at onset
genotype
Discinesias
Fluctuaciones
Glutamato
Humans
Inhibidores de la MAO
Motor symptoms
Multiple system atrophy
Neurología
Parkinson Disease
Parkinson’s disease
Safinamida
Spain
Spanish population
cohort analysis
epistasis
gene
gene expression
genetic analysis